Prevalence of syphilis among people living with HIV who attend a large urban antiretroviral therapy clinic in Panama: a cross-sectional epidemiological study.

IF 3.8 Q2 INFECTIOUS DISEASES
Therapeutic Advances in Infectious Disease Pub Date : 2024-05-30 eCollection Date: 2024-01-01 DOI:10.1177/20499361241256290
Amanda Gabster, Félix Fernández Díaz, Yamitzel Zaldívar, Michelle Hernández, Juan Miguel Pascale, Angelique Orillac, Samuel Moreno-Wynter, Casey D Xavier Hall, Mónica Jhangimal, Anyi Yu-Pon, Cristel Rodríguez-Vargas, Diogenes Arjona-Miranda, Bárbara Fuentes, Germán Henestroza, Ana Belén Araúz
{"title":"Prevalence of syphilis among people living with HIV who attend a large urban antiretroviral therapy clinic in Panama: a cross-sectional epidemiological study.","authors":"Amanda Gabster, Félix Fernández Díaz, Yamitzel Zaldívar, Michelle Hernández, Juan Miguel Pascale, Angelique Orillac, Samuel Moreno-Wynter, Casey D Xavier Hall, Mónica Jhangimal, Anyi Yu-Pon, Cristel Rodríguez-Vargas, Diogenes Arjona-Miranda, Bárbara Fuentes, Germán Henestroza, Ana Belén Araúz","doi":"10.1177/20499361241256290","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Syphilis is a serious global public health challenge. Despite prior progress in syphilis control, incidence has been increasing in recent years. Syphilis is a common coinfection among people living with HIV (PLHIV). In Panama, few data describe syphilis prevalence among PLHIV. We describe syphilis antibody and high-titer (⩾1:8) active syphilis prevalence and associated factors among individuals who attended an antiretroviral clinic.</p><p><strong>Methods: </strong>A cross-sectional study was undertaken during February-March 2022 and September-October 2022 for adults (⩾18 year) assigned male and female at birth, respectively. Participants provided peripheral blood samples and self-administered a questionnaire. Samples were screened using immunochromatography; antibody-positive samples were tested using rapid plasma regain to 1:512 dilutions. Logistic regression was used to identify factors associated with syphilis antibody and high-titer active syphilis.</p><p><strong>Results: </strong>In all, 378 participants gave blood samples; 377 individuals participated in the questionnaire (216 self-reported male sex [males], 158 female [females], and three intersex individuals). Median age was 36 years (interquartile range: 28-45 years). Overall, syphilis antibody prevalence was 32.3% (122/378) (males, 50.7% [108/2013]; females, 5.7% [9/158]; intersex individuals, 100.0% (3/3)], <i>p</i> < 0.01. High-titer active syphilis was found among 24.6% (<i>n</i> = 30) of samples with positive antibody test (males 27.8% [<i>n</i> = 30], females 0.0% [0/9], intersex individuals 0.0% [0/3]). Antibody positivity was associated in the multivariable model with males (50.7%, AOR = 24.6, 95%CI: 1.57-384.53). High-titer active syphilis was associated with younger participant age (18-30 years, 13.2%, OR = 4.82, 95%CI: 1.17-19.83); 31-40 years, 7.8%, OR = 4.24, 95%CI: 1.04-17.21 <i>versus</i> 3.2% >40 years), homosexual identity (16.0% OR = 34.2, 95%CI: 4.50-259.27 <i>versus</i> 0.6% among heterosexual identity); in the multivariable model, associated with sexual identity (bisexual 19.1%, AOR = 10.89, 95%CI: 1.00-119.06) compared to heterosexual identity (0.6%) and weakly associated with concurrency (⩾1 ongoing sexual relationships, 15.9%, AOR = 3.09, 95%CI: 0.94-10.14).</p><p><strong>Conclusion: </strong>This study found very high prevalence of syphilis antibodies and high-titer syphilis among PLHIV in Panama. Those most affected are males, younger in age, those who practice concurrent sexual relationships, and those who reported homosexual and bisexual identity. Targeted interventions should include repetitive testing and treatment, especially among individuals who may be at increased infection risk.</p>","PeriodicalId":46154,"journal":{"name":"Therapeutic Advances in Infectious Disease","volume":"11 ","pages":"20499361241256290"},"PeriodicalIF":3.8000,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11141218/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Infectious Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20499361241256290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Syphilis is a serious global public health challenge. Despite prior progress in syphilis control, incidence has been increasing in recent years. Syphilis is a common coinfection among people living with HIV (PLHIV). In Panama, few data describe syphilis prevalence among PLHIV. We describe syphilis antibody and high-titer (⩾1:8) active syphilis prevalence and associated factors among individuals who attended an antiretroviral clinic.

Methods: A cross-sectional study was undertaken during February-March 2022 and September-October 2022 for adults (⩾18 year) assigned male and female at birth, respectively. Participants provided peripheral blood samples and self-administered a questionnaire. Samples were screened using immunochromatography; antibody-positive samples were tested using rapid plasma regain to 1:512 dilutions. Logistic regression was used to identify factors associated with syphilis antibody and high-titer active syphilis.

Results: In all, 378 participants gave blood samples; 377 individuals participated in the questionnaire (216 self-reported male sex [males], 158 female [females], and three intersex individuals). Median age was 36 years (interquartile range: 28-45 years). Overall, syphilis antibody prevalence was 32.3% (122/378) (males, 50.7% [108/2013]; females, 5.7% [9/158]; intersex individuals, 100.0% (3/3)], p < 0.01. High-titer active syphilis was found among 24.6% (n = 30) of samples with positive antibody test (males 27.8% [n = 30], females 0.0% [0/9], intersex individuals 0.0% [0/3]). Antibody positivity was associated in the multivariable model with males (50.7%, AOR = 24.6, 95%CI: 1.57-384.53). High-titer active syphilis was associated with younger participant age (18-30 years, 13.2%, OR = 4.82, 95%CI: 1.17-19.83); 31-40 years, 7.8%, OR = 4.24, 95%CI: 1.04-17.21 versus 3.2% >40 years), homosexual identity (16.0% OR = 34.2, 95%CI: 4.50-259.27 versus 0.6% among heterosexual identity); in the multivariable model, associated with sexual identity (bisexual 19.1%, AOR = 10.89, 95%CI: 1.00-119.06) compared to heterosexual identity (0.6%) and weakly associated with concurrency (⩾1 ongoing sexual relationships, 15.9%, AOR = 3.09, 95%CI: 0.94-10.14).

Conclusion: This study found very high prevalence of syphilis antibodies and high-titer syphilis among PLHIV in Panama. Those most affected are males, younger in age, those who practice concurrent sexual relationships, and those who reported homosexual and bisexual identity. Targeted interventions should include repetitive testing and treatment, especially among individuals who may be at increased infection risk.

在巴拿马一个大型城市抗逆转录病毒治疗诊所就诊的艾滋病毒感染者中梅毒的流行率:一项横断面流行病学研究。
背景:梅毒是一项严峻的全球公共卫生挑战。尽管此前在梅毒控制方面取得了进展,但近年来发病率仍在上升。梅毒是艾滋病病毒感染者(PLHIV)中常见的合并感染。在巴拿马,很少有数据描述梅毒在艾滋病病毒感染者中的流行情况。我们描述了梅毒抗体和高滴度(⩾1:8)活动性梅毒在抗逆转录病毒诊所就诊者中的流行情况及相关因素:在 2022 年 2 月至 3 月和 2022 年 9 月至 10 月期间分别对出生时被指定为男性和女性的成年人(⩾18 岁)进行了横断面研究。参与者提供外周血样本并自行填写问卷。样本采用免疫层析法进行筛选;抗体阳性样本采用快速血浆回输法进行检测,稀释比例为 1:512。采用逻辑回归法确定梅毒抗体和高滴度活动梅毒的相关因素:共有 378 名参与者提供了血液样本;377 人参与了问卷调查(216 人自称为男性,158 人自称为女性,3 人为双性人)。年龄中位数为 36 岁(四分位数间距:28-45 岁)。总体而言,在抗体检测呈阳性的样本中,梅毒抗体流行率为 32.3%(122/378)(男性,50.7% [108/2013];女性,5.7% [9/158];双性人,100.0% (3/3)],P n = 30)(男性 27.8% [n = 30];女性 0.0% [0/9];双性人 0.0% [0/3])。在多变量模型中,抗体阳性与男性有关(50.7%,AOR = 24.6,95%CI:1.57-384.53)。高滴度活动梅毒与参与者年龄较小(18-30 岁,13.2%,OR = 4.82,95%CI:1.17-19.83);31-40 岁,7.8%,OR = 4.24,95%CI:1.04-17.21 与 3.2% >40 岁)、同性恋身份(16.0% OR = 34.2,95%CI:4.50-259.27 与 0.在多变量模型中,与异性恋身份(0.6%)相比,与性身份(双性恋 19.1%,AOR = 10.89,95%CI:1.00-119.06)相关,与并发症(⩾1 个持续性关系,15.9%,AOR = 3.09,95%CI:0.94-10.14)弱相关:这项研究发现,在巴拿马的艾滋病毒携带者中,梅毒抗体和高滴度梅毒的发病率非常高。受影响最严重的人群是男性、年轻女性、同时有性关系的人群以及报告有同性恋和双性恋身份的人群。有针对性的干预措施应包括重复检测和治疗,特别是在感染风险可能增加的人群中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
8.80%
发文量
64
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信